Coatue Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-117,415
Closed -$91.5M 76
2025
Q2
$91.5M Sell
117,415
-66,306
-36% -$51.5M 0.26% 42
2025
Q1
$152M Sell
183,721
-30,263
-14% -$25.2M 0.67% 32
2024
Q4
$165M Sell
213,984
-33,966
-14% -$28.1M 0.56% 37
2024
Q3
$220M Buy
247,950
+40,904
+20% +$36.8M 0.82% 33
2024
Q2
$187M Sell
207,046
-37,064
-15% -$29.6M 0.73% 31
2024
Q1
$190M Buy
244,110
+30,770
+14% +$21.9M 0.74% 32
2023
Q4
$124M Sell
213,340
-136,310
-39% -$79.6M 0.52% 36
2023
Q3
$188M Buy
349,650
+175,734
+101% +$90.6M 0.95% 27
2023
Q2
$81.6M Buy
+173,916
New +$72.9M 0.4% 32

Other funds holding LLY

Coatue Management's LLY Position: Q3 2025 in Review

Coatue Management sold out of Eli Lilly (LLY) in Q3 2025, closing a stake of 117,415 shares — an estimated $91.5M sold.

Coatue Management first reported a position in LLY in Q2 2023 and held it in 9 quarters. The position peaked at $220M in Q3 2024. 3,897 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

  • Coatue Management reported no remaining Eli Lilly position as of Q3 2025 after selling out during the quarter.
  • Coatue Management sold 117,415 Eli Lilly shares in Q3 2025, an estimated $91.5M.
  • Coatue Management first reported a position in Eli Lilly in Q2 2023 and held it in 9 quarters.
  • Coatue Management's Eli Lilly position peaked at $220M in Q3 2024.
  • 3,897 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on Coatue Management's 13F filing for Q3 2025, filed 14 Nov 2025.